Calamine Lotion
NDC 70677-1316
Product Information
Calamine (calamine and zinc oxide) is a OTC MONOGRAPH DRUG-approved product labeled by Strategic Sourcing Services. This medication is used to treat and prevent diaper rash and other minor skin irritations (e. It is supplied as a lotion for topical administration. This product entry covers the primary NDC 70677-1316 and its associated package configuration. This profile includes active and inactive ingredient UNII references and FDA labeling data.
Primary Identification
Clinical Specifications
Labeler & Regulatory Data
Marketing Timeline
Code Structure Chart
Product Details
What is NDC 70677-1316?
What are the uses of this product?
What are Active Ingredients of this product?
- ZINC OXIDE 160 mg/mL - A mild astringent and topical protectant with some antiseptic action. It is also used in bandages, pastes, ointments, dental cements, and as a sunblock.
Which are the associated UNII Codes?
The UNII codes for the active ingredients in this product are:
- ZINC OXIDE (UNII: SOI2LOH54Z)
- ZINC CATION (UNII: 13S1S8SF37) (Active Moiety)
Which are the Inactive Ingredients associated UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- GLYCERIN (UNII: PDC6A3C0OX)
- MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)
- BENTONITE (UNII: A3N5ZCN45C)
- CALCIUM HYDROXIDE (UNII: PF5DZW74VN)
- WATER (UNII: 059QF0KO0R)
- CARRAGEENAN (UNII: 5C69YCD2YJ)
- XANTHAN GUM (UNII: TTV12P4NEE)
What is the NDC to RxNorm Crosswalk for this product?
- RxCUI: 617954 - calamine 8 % / zinc oxide 8 % Topical Lotion
- RxCUI: 617954 - calamine 80 MG/ML / zinc oxide 80 MG/ML Topical Lotion
- RxCUI: 617954 - Calamine 80 MG/ML / ZNO 80 MG/ML Topical Lotion
Which are the Pharmacologic Classes of this product?
* Please review the full disclaimer at the bottom of this page.